CIK 0000876343
- Non-accelerated filer
- Smaller reporting company
Lineage Cell Therapeutics, Inc.
Sign in to watch- Ticker
- LCTX
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 943127919
- Phone
- +1 510-521-3390
- Business address
- 2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, 92008
- Former names
- BIOTIME INC
- 4 Shares withheld for taxes Co-Chief Executive Officer gave up 2,057 shares (to pay taxes)
- 4 Shares withheld for taxes Co-Chief Executive Officer gave up 686 shares (to pay taxes)
- 4 Open-market buy Director bought 2,692,307 shares at $2.60 ($6,999,998)
- 4 Shares withheld for taxes Co-Chief Executive Officer gave up 1,762 shares (to pay taxes)
- 4 Shares withheld for taxes Co-Chief Executive Officer gave up 588 shares (to pay taxes)
- 4 Open-market buy Chief Financial Officer bought 2,000 shares at $2.64 ($5,285)
- 4 Open-market buy Director bought 10,000 shares at $2.60 ($25,955)
- 4 Open-market buy Co-Chief Executive Officer bought 2,000 shares at $2.60 ($5,198)
- 4 Open-market buy Director bought 2,396 shares at $2.50 ($5,990)
- 4 Open-market buy General Counsel bought 7,500 shares at $2.58 ($19,376)
- 4 Open-market buy Co-Chief Executive Officer bought 7,500 shares at $2.50 ($18,750)
- 4 Returned to the company KINGSLEY ALFRED D returned 300,000 shares (to the company)
- 4 Open-market buy Director bought 150,000 shares at $2.80 ($420,000)
- 4 Open-market sale KINGSLEY ALFRED D sold 150,000 shares at $2.80 ($420,000)
- 4 Shares withheld for taxes Co-Chief Executive Officer gave up 1,762 shares (to pay taxes)
- 4 Shares withheld for taxes Co-Chief Executive Officer gave up 587 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 11 of 37 · 722 filings